Wells Fargo Maintains Microchip Technology Incorporated - Preferred Stock (MCHPP) Equal-Weight Recommendation

Wells Fargo maintained an "Equal-Weight" recommendation for Microchip Technology Incorporated - Preferred Stock (MCHPP), with an average one-year price target of $72.00, implying a 35.51% upside from its recent closing price of $53.13. Institutional ownership in MCHPP increased significantly, with the number of funds reporting positions rising by 12.20% to 138 and total shares owned by institutions growing 7.70% to 53,445K, reflecting increased portfolio allocation despite some varied individual fund activity.

Analysis

Wells Fargo maintained an "Equal-Weight" recommendation for Microchip Technology Incorporated - Preferred Stock (MCHPP) on November 7, 2025, despite an average one-year price target of $72.00. This target implies a substantial 35.51% upside from the recent closing price of $53.13, with a projected annual non-GAAP EPS of $1.27. The analyst consensus suggests significant potential appreciation, contrasting with the neutral rating.

Institutional ownership in MCHPP has shown a clear upward trend, with 138 funds reporting positions, marking a 12.20% increase in owners last quarter. Total institutional shares rose by 7.70% to 53,445K, and the average portfolio weight dedicated to MCHPP increased by 38.92%. This broad accumulation indicates growing investor sentiment towards the preferred stock.

However, individual fund actions present a nuanced picture; while Capital International Investors and AMRMX increased their MCHPP allocations by 17.03% and 24.45% respectively, Voya Investment Management significantly decreased its portfolio allocation by 58.06%. This divergence suggests varying conviction levels among large institutional holders, despite the overall positive flow.

Key Decisions for Investors

• Investors should evaluate the discrepancy between Wells Fargo's "Equal-Weight" rating and the substantial 35.51% implied price target upside, considering the underlying assumptions for the $1.27 non-GAAP EPS.
• Monitor future institutional ownership filings for MCHPP to discern if the overall positive accumulation trend continues or if individual fund divergence becomes more pronounced.
• Assess the preferred stock's specific yield and risk characteristics in light of the projected growth and mixed institutional conviction, comparing it to alternative fixed-income or equity opportunities.